Douglas Brian Flieder, M.D. is an anatomic pathology and clinical pathology pathology in Philadelphia, PA with 32 years of experience. The provider is a pathologist deals with the causes and nature of disease and contributes to diagnosis, prognosis and treatment through knowledge gained by the laboratory application of the biologic, chemical and physical sciences. A pathologist uses information gathered from the microscopic examination of tissue specimens, cells and body fluids, and from clinical laboratory tests on body fluids and secretions for the diagnosis, exclusion and monitoring of disease. Douglas Brian Flieder, M.D. NPI is 1356368211. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Graduation Year:1992
The provider's business location address is:
333 COTTMAN AVENUE
FOX CHASE CANCER CENTER
PHILADELPHIA, PA
ZIP 19111
Phone: (215) 728-6900
Fax: (215) 728-2899
The NPI 1356368211 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
- Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
- Special stained specimen slides to examine tissue (HCPCS:88341)
- Tissue or cell analysis by immunologic technique (HCPCS:88342)
- Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
The enumeration date for this NPI number is 7/16/2006 and was last updated on 4/17/2018.